Early microglial response to amyloid plaques drives sleep loss in Alzheimer's disease
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Nicholas J Constantino und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University of Kentucky, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Microglia, Plaque, Amyloid, Alzheimer Disease, Sleep Deprivation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Institutional Development Award, NIH Center of Biomedical Research Excellence (COBRE) in CNS Metabolism, NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Sleep disruption is an early feature of Alzheimer's disease (AD), but the cellular mechanisms linking amyloid pathology to sleep loss remain unclear. METHODS Electroencephalography/electromyography (EEG/EMG) recordings, quantitative EEG analysis, and sleep deprivation were performed in APPswe/PSEN1dE9 (APP/PS1) mice at different stages of pathology relative to normal aging. Amyloid burden and microglial density were quantified with whole‐brain light‐sheet microscopy. CSF1R‐mediated microglial depletion explored effects of microglia on sleep loss. RESULTS Amyloid plaques caused non–rapid eye movement (NREM) sleep loss that did not worsen with increased plaque burden. Aging reduced REM sleep and eliminated sleep rebound. Amyloid pathology was associated with cortical hyperexcitability, network desynchrony, and microglial expansion extending beyond plaque‐bearing regions into thalamocortical and white matter networks governing sleep–wake dynamics. Microglial depletion restored > 2 hours of sleep per day without altering amyloid burden. DISCUSSION Microglia are a causal, reversible driver of amyloid‐associated sleep loss, positioning sleep and EEG‐based metrics as sensitive biomarkers of presymptomatic AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, University of Kentucky, Lexington, Kentucky, USA.
- Department of Neuroscience, University of Kentucky, Lexington, Kentucky, USA.
- Department of Psychiatry, Alzheimer's Disease Research Center, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
- LifeCanvas Technologies, Cambridge, Massachusetts, USA.
- Sanders Brown Center of Aging, University of Kentucky, Lexington, Kentucky, USA.
Förderung
- Institutional Development Award
- NIH Center of Biomedical Research Excellence (COBRE) in CNS Metabolism
- NIA NIH HHS
- NIGMS
- NIGMS NIH HHS
- BrightFocus Foundation
- Coins for Alzheimer's Research Trust
- Cure Alzheimer's Fund
Zitieren
APA
Constantino, N. J., Irmen, R. E., Lanning, M. J., Turner, S. M., Ashley, C. C., Carroll, C. M., Neary, E. M., Rubinow, D., Snipes, J. A., & Macauley, S. L. (2026). Early microglial response to amyloid plaques drives sleep loss in Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71579
Vancouver
Constantino NJ, Irmen RE, Lanning MJ, Turner SM, Ashley CC, Carroll CM, et al. Early microglial response to amyloid plaques drives sleep loss in Alzheimer's disease. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71579
BibTeX
@article{Constantino2026,
author = {Constantino, Nicholas J and Irmen, Riley E and Lanning, Matthew J and Turner, Sierra M and Ashley, Clair C and Carroll, Caitlin M and Neary, Evan M and Rubinow, Dave and Snipes, J Andy and Macauley, Shannon L},
title = {Early microglial response to amyloid plaques drives sleep loss in Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71579}
}
EUVIMED